855 related articles for article (PubMed ID: 21883939)
1. Reactive oxygen species and endothelial function--role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases.
Montezano AC; Touyz RM
Basic Clin Pharmacol Toxicol; 2012 Jan; 110(1):87-94. PubMed ID: 21883939
[TBL] [Abstract][Full Text] [Related]
2. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
Paravicini TM; Touyz RM
Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
Montezano AC; Touyz RM
Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase.
Sorescu GP; Song H; Tressel SL; Hwang J; Dikalov S; Smith DA; Boyd NL; Platt MO; Lassègue B; Griendling KK; Jo H
Circ Res; 2004 Oct; 95(8):773-9. PubMed ID: 15388638
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
6. Chronic escitalopram treatment induces erectile dysfunction by decreasing nitric oxide bioavailability mediated by increased nicotinamide adenine dinucleotide phosphate oxidase activity and reactive oxygen species production.
Kassan M; Lasker GF; Sikka SC; Mandava SH; Gokce A; Matrougui K; Hellstrom WJ; Kadowitz PJ; Serefoglu EC
Urology; 2013 Nov; 82(5):1188.e1-7. PubMed ID: 24242893
[TBL] [Abstract][Full Text] [Related]
7. Endothelial nitric oxide synthase in vascular disease: from marvel to menace.
Förstermann U; Münzel T
Circulation; 2006 Apr; 113(13):1708-14. PubMed ID: 16585403
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies.
Montezano AC; Touyz RM
Ann Med; 2012 Jun; 44 Suppl 1():S2-16. PubMed ID: 22713144
[TBL] [Abstract][Full Text] [Related]
9. The Nox family of NADPH oxidases: friend or foe of the vascular system?
Takac I; Schröder K; Brandes RP
Curr Hypertens Rep; 2012 Feb; 14(1):70-8. PubMed ID: 22071588
[TBL] [Abstract][Full Text] [Related]
10. Endothelial NADPH oxidases: which NOX to target in vascular disease?
Drummond GR; Sobey CG
Trends Endocrinol Metab; 2014 Sep; 25(9):452-63. PubMed ID: 25066192
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and endothelial dysfunction: clinical evidence and therapeutic implications.
Higashi Y; Maruhashi T; Noma K; Kihara Y
Trends Cardiovasc Med; 2014 May; 24(4):165-9. PubMed ID: 24373981
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species and vascular biology: implications in human hypertension.
Touyz RM; Briones AM
Hypertens Res; 2011 Jan; 34(1):5-14. PubMed ID: 20981034
[TBL] [Abstract][Full Text] [Related]
13. Endothelial function and hypertension.
Landmesser U; Drexler H
Curr Opin Cardiol; 2007 Jul; 22(4):316-20. PubMed ID: 17556884
[TBL] [Abstract][Full Text] [Related]
14. Lysimachia clethroides extract promote vascular relaxation via endothelium-dependent mechanism.
Lee JO; Chang K; Kim CY; Jung SH; Lee SW; Oak MH
J Cardiovasc Pharmacol; 2010 May; 55(5):481-8. PubMed ID: 20164788
[TBL] [Abstract][Full Text] [Related]
15. Composition and functions of vascular nicotinamide adenine dinucleotide phosphate oxidases.
Brandes RP; Schröder K
Trends Cardiovasc Med; 2008 Jan; 18(1):15-9. PubMed ID: 18206804
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of hypertension: role of Nox family NADPH oxidases.
Sedeek M; Hébert RL; Kennedy CR; Burns KD; Touyz RM
Curr Opin Nephrol Hypertens; 2009 Mar; 18(2):122-7. PubMed ID: 19430333
[TBL] [Abstract][Full Text] [Related]
17. Novel Nox homologues in the vasculature: focusing on Nox4 and Nox5.
Montezano AC; Burger D; Ceravolo GS; Yusuf H; Montero M; Touyz RM
Clin Sci (Lond); 2011 Feb; 120(4):131-41. PubMed ID: 21039341
[TBL] [Abstract][Full Text] [Related]
18. Vascular NADPH oxidases as drug targets for novel antioxidant strategies.
Guzik TJ; Harrison DG
Drug Discov Today; 2006 Jun; 11(11-12):524-33. PubMed ID: 16713904
[TBL] [Abstract][Full Text] [Related]
19. Roles of endothelial oxidases in endothelium-derived hyperpolarizing factor responses in mice.
Takaki A; Morikawa K; Murayama Y; Yamagishi H; Hosoya M; Ohashi J; Shimokawa H
J Cardiovasc Pharmacol; 2008 Dec; 52(6):510-7. PubMed ID: 19034034
[TBL] [Abstract][Full Text] [Related]
20. Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells.
Tumur Z; Niwa T
Am J Nephrol; 2009; 29(6):551-7. PubMed ID: 19129694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
